Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05112289 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate White Matter Hyperintensities in Migraine

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Aug 2026 → Sep 3, 2028
See other at-risk trials from Mayo Clinic

Record History

  1. Primary and study completion pushed from Aug 2026 to Sep 3, 2028 Eligibility criteria expanded, about 27 words Show 1 more changeShow less
    • Eligibility criteria expanded, about 27 words
  2. Primary and study completion dates: Aug 2025 to Aug 2026v5
  3. Primary and study completion dates: Aug 2024 to Aug 2025v4
  4. Primary and study completion dates: Aug 16, 2023 to Aug 2024 Trial status: Recruiting to Active, Not Recruiting · Site details revisedv3 Show 2 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
  5. Primary and study completion dates: Aug 16, 2022 to Aug 16, 2023v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,019 trials monitored
See 121 trials at risk
Multiple Sclerosis
991 trials monitored
See 36 trials at risk
Migraine
467 trials monitored
See 24 trials at risk
The purpose of this research is to better understand brain white matter hyperintensities (WMH) in women with migraines
Trial Details
NCT Number NCT05112289
Lead Sponsor Mayo Clinic
Conditions Migraine, Small Vessel Ischemic Disease, Multiple Sclerosis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov